{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:30:48Z","timestamp":1773685848112,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Journal Armed Forces India"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.mjafi.2021.09.005","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T18:04:13Z","timestamp":1637777053000},"page":"125-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Drug update - Baloxavir marboxil: Latest entrant into the arena of pharmacotherapy of influenza"],"prefix":"10.1016","volume":"78","author":[{"given":"A.","family":"Tejus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.G.","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sapna","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Fadil","family":"Salmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mjafi.2021.09.005_bib1","doi-asserted-by":"crossref","first-page":"i6258","DOI":"10.1136\/bmj.i6258","article-title":"Influenza","volume":"355","author":"Ghebrehewet","year":"2016","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.mjafi.2021.09.005_bib2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/v8040096","article-title":"Current approaches for diagnosis of influenza virus infections in humans","volume":"8","author":"Vemula","year":"2016","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.mjafi.2021.09.005_bib3","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.ajpath.2014.08.030","article-title":"The role of viral, host, and secondary bacterial factors in influenza pathogenesis","volume":"185","author":"Kash","year":"2015","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.mjafi.2021.09.005_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161195","article-title":"Epidemiological and virological characterization of influenza B virus infections","volume":"11","author":"Sharabi","year":"2016","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.mjafi.2021.09.005_bib5","first-page":"69","article-title":"Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: influenza life-cycle and currently available drugs","volume":"55","author":"Gasparini","year":"2014","journal-title":"J Prev Med Hyg"},{"issue":"10","key":"10.1016\/j.mjafi.2021.09.005_bib6","article-title":"Aureonitol, a fungi-derived tetrahydrofuran, inhibits influenza replication by targeting its surface glycoprotein hemagglutinin","volume":"10","author":"Sacramento","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.mjafi.2021.09.005_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/nyas.12462","article-title":"Continuing challenges in influenza","volume":"1323","author":"Webster","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.mjafi.2021.09.005_bib8","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nsmb.1779","article-title":"Structures of influenza A proteins and insights into antiviral drug targets","volume":"17","author":"Das","year":"2010","journal-title":"Nat Struct Mol Biol"},{"issue":"37","key":"10.1016\/j.mjafi.2021.09.005_bib9","doi-asserted-by":"crossref","first-page":"28403","DOI":"10.1074\/jbc.R110.129809","article-title":"Influenza hemagglutinin and neuraminidase membrane glycoproteins","volume":"285","author":"Gamblin","year":"2010","journal-title":"J Biol Chem"},{"issue":"559","key":"10.1016\/j.mjafi.2021.09.005_bib10","first-page":"1","article-title":"Structural and functional motifs in influenza virus RNAs","volume":"9","author":"Ferhadian","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.mjafi.2021.09.005_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jviromet.2014.02.005","article-title":"An efficient screening system for influenza virus cap-dependent endonuclease inhibitors","volume":"202","author":"Shibagaki","year":"2014","journal-title":"J Virol Methods"},{"key":"10.1016\/j.mjafi.2021.09.005_bib12","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1261\/rna.054221.115","article-title":"Influenza A virus preferentially snatches noncoding RNA caps","volume":"21","author":"Weifeng","year":"2015","journal-title":"RNA"},{"issue":"10","key":"10.1016\/j.mjafi.2021.09.005_bib13","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1093\/nar\/gkv333","article-title":"Sequencing the cap-snatching repertoire of H1N1 influenza provides insight into the mechanism of viral transcription initiation","volume":"43","author":"Koppstein","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"559","key":"10.1016\/j.mjafi.2021.09.005_bib14","first-page":"1","article-title":"Structural and functional motifs in influenza virus RNAs","volume":"9","author":"Ferhadian","year":"2018","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.mjafi.2021.09.005_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/v8060165","article-title":"The feat of packaging eight unique genome segments","volume":"8","author":"Giese","year":"2016","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.mjafi.2021.09.005_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7774\/cevr.2018.7.1.1","article-title":"Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure","volume":"7","author":"Yoo","year":"2018","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.mjafi.2021.09.005_bib17","first-page":"187","article-title":"Influenza treatment and prophylaxis with neuraminidase inhibitors: a review","volume":"6","author":"Kamali","year":"2013","journal-title":"Infect Drug Resist"},{"issue":"4","key":"10.1016\/j.mjafi.2021.09.005_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060348","article-title":"The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews","volume":"8","author":"Michiels","year":"2013","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.mjafi.2021.09.005_bib19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s13238-016-0287-0","article-title":"Ribavirin is effective against drug-resistant H7N9 influenza virus infections","volume":"7","author":"Bi","year":"2016","journal-title":"Protein Cell"},{"key":"10.1016\/j.mjafi.2021.09.005_bib20","first-page":"k453","article-title":"Sixty seconds on . . . baloxavir","volume":"363","author":"Hawkes","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.mjafi.2021.09.005_bib21","doi-asserted-by":"crossref","DOI":"10.1007\/s40261-018-0710-9","article-title":"Safety, tolerability, and pharmacokinetics of the novel anti-infuenza agent baloxavir marboxil in healthy adults: phase I study findings","author":"Koshimichi","year":"2018","journal-title":"Clin Drug Invest"},{"issue":"11","key":"10.1016\/j.mjafi.2021.09.005_bib22","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40261-018-0697-2","article-title":"Evaluation of drug-drug interaction potential between baloxavir marboxil and Oseltamivir in healthy subjects","volume":"38","author":"Kawaguchi","year":"2018","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.mjafi.2021.09.005_bib23","series-title":"Poster presented at ID week; 2016 Oct 26-30; New Orleans, LA","article-title":"S-033447\/S-033188, a novel small molecule inhibitor of Cap-dependent endonuclease of influenza A and B virus: in\u00a0vitro antiviral activity against clinical strains","author":"Noshi","year":"2016"},{"issue":"5","key":"10.1016\/j.mjafi.2021.09.005_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217307","article-title":"Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models","volume":"14","author":"Fukao","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.mjafi.2021.09.005_bib25","series-title":"Poster presented at ID week; 2018 Oct 3-7; San Francisco, CA","article-title":"Therapeutic effects of baloxavir marboxil against influenza A virus infection in ferrets","author":"Kitano","year":"2018"},{"issue":"suppl 1","key":"10.1016\/j.mjafi.2021.09.005_bib26","doi-asserted-by":"crossref","first-page":"S371","DOI":"10.1093\/ofid\/ofx163.910","article-title":"Synergistic antiviral activity of S-033188\/S-033447, a novel inhibitor of influenza virus cap-dependent endonuclease, in combination with neuraminidase inhibitors in\u00a0vitro","volume":"4","author":"Kitano","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.mjafi.2021.09.005_bib27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.mjafi.2021.09.005_bib28","doi-asserted-by":"crossref","first-page":"S734","DOI":"10.1093\/ofid\/ofx180.001","article-title":"Cap-dependent endonuclease inhibitor S-033188 for the treatment of influenza: results from a phase 3, randomized, double-blind, placebo- and active-controlled study in otherwise healthy adolescents and adults with seasonal influenza","volume":"4","author":"Portsmouth","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.mjafi.2021.09.005_bib29","series-title":"Oral abstract presented at ID week; 2018 Oct 3-7; San Francisco, CA","article-title":"Phase 3 trial of baloxavir marboxil in high risk influenza patients (CAPSTONE-2 study)","author":"Ison","year":"2018"},{"issue":"3","key":"10.1016\/j.mjafi.2021.09.005_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/irv.12446","article-title":"Influenza antivirals currently in late-phase clinical trial","volume":"11","author":"Koszalka","year":"2017","journal-title":"Influenza Other Respir Viruses"}],"container-title":["Medical Journal Armed Forces India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123721002616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123721002616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T11:50:19Z","timestamp":1759837819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0377123721002616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0377123721002616"],"URL":"https:\/\/doi.org\/10.1016\/j.mjafi.2021.09.005","relation":{},"ISSN":["0377-1237"],"issn-type":[{"value":"0377-1237","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug update - Baloxavir marboxil: Latest entrant into the arena of pharmacotherapy of influenza","name":"articletitle","label":"Article Title"},{"value":"Medical Journal Armed Forces India","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mjafi.2021.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}